TEMLIMM Trademark

Trademark Overview

On Thursday, December 18, 2014, a trademark application was filed for TEMLIMM with the United States Patent and Trademark Office. The USPTO has given the TEMLIMM trademark a serial number of 86484985. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 11, 2022. This trademark is owned by AstraZeneca AB. The TEMLIMM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders
temlimm

General Information

Serial Number86484985
Word MarkTEMLIMM
Filing DateThursday, December 18, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 11, 2022
Registration Number4798770
Registration DateTuesday, August 25, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, March 11, 2022CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 25, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 25, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 9, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 30, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, April 30, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 30, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, April 30, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, April 23, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 23, 2015FINAL REFUSAL E-MAILED
Thursday, April 23, 2015FINAL REFUSAL WRITTEN
Thursday, April 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 20, 2015ASSIGNED TO LIE
Thursday, April 16, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 3, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 3, 2015NON-FINAL ACTION E-MAILED
Friday, April 3, 2015NON-FINAL ACTION WRITTEN
Saturday, March 28, 2015ASSIGNED TO EXAMINER
Tuesday, December 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 22, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

temlimm diseases disorders substances preparations pharmaceutical infection gastrointestinal system nervous inflammation